[ SBIR/STTR Rosters ]

The Oncology 2 – Translational Clinical Small Business Activities Special Emphasis Panels [OTC SBIR/STTR SEPs] review small business applications including Small Business Innovation Research [SBIR] and Small Business Technology Transfer [STTR] grant applications concerned with basic, preclinical, and clinical studies in the oncological sciences.

Cancer Drug Development and Therapeutics SBIR/STTR SEP [CDDT OTC (10)]

This Special Emphasis Panel reviews applications addressing the experimental therapy of neoplastic diseases in in vitro systems and in vivo model systems, including some early-stage, pilot clinical trials. The major emphasis of this study section is on the rational development of novel therapeutic strategies that have a significant potential for translation to the clinic.

Specific areas covered by the CDDT SBIR/STTR SEP include:

• Development and evaluation of anti-cancer therapeutic agents and drug deliveries in both in vitro and in vivo tumor model systems
• Identification and validation of new cancer relevant molecular targets for therapeutic intervention
• Development of gene therapy with viral or non-viral based delivery in animal models
• Mechanisms of drug resistance and strategies to circumvent resistance
• Natural compounds that modulate signal transudation, cell cycle, angiogenic or apoptotic pathways
  

Study section with most closely related areas of similar science listed in rank order are:

Biological Chemistry and Macromolecular Biophysics SBIR/STTR SEPs [BCMB SBIR/STTR SEPs]      
Genes, Genomes and Genetic SBIR/STTR SEP [GGG (10)] 
Bioengineering Sciences and Technology SBIR/STTR SEPs [BST SBIR/STTR SEPs] 
Immunology SBIR/STTR SEP [IMM-G] 
Diabetes, Metabolism, Nutrition and Obesity SBIR/STTR SEP [EMNR E10B]